Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Bekker, A; Schaaf, H S; Draper, H R; van der Laan, L; Murray, S; Wiesner, L; Donald, P R; McIlleron, H M; Hesseling, A C.
Antimicrob Agents Chemother
; 60(4): 2171-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26810651
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection.
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Six-month therapy for abdominal tuberculosis.
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.